CD38 and diabetic cardiomyopathy: To further clarify the protective roles of CD38 in diabetic cardiomyopathy in vitro, we examined the effects of CD38 on high glucose plus palmitic acid (HG/PA)-induced cardiomyocytic damage using CD38 knockdown H9C2 stable cell lines.